Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Allarity Therapeutics (ALLR) EBIAT (2024 - 2025)

Allarity Therapeutics' EBIAT history spans 2 years, with the latest figure at -$3.4 million for Q4 2025.

  • For Q4 2025, EBIAT rose 54.74% year-over-year to -$3.4 million; the TTM value through Dec 2025 reached -$11.2 million, up 54.19%, while the annual FY2025 figure was -$11.2 million, 54.19% up from the prior year.
  • EBIAT reached -$3.4 million in Q4 2025 per ALLR's latest filing, down from -$2.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of -$1.6 million in Q2 2024 to a low of -$11.6 million in Q3 2024.